ghk-cu tolerance desensitization long-term efficacy Peptide ghk-cu tolerance or desensitization or
Description
(1.1) initial treatment, in combination with cisplatin, of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery
Buy peptide combos from Pharma Lab Global today
PMID: 1299794
10.4161/cc.5.5.2538 [DOI] [PMC free article] [PubMed] [Google Scholar] Stupnisek, M
